BridgeMD
Compares treatment options for Acute Kidney Injury (Nontraumatic)
Official title WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients
ClinicalTrials.gov ID: NCT07447791
What this study is testing
- What it's testing
- Acute kidney injury is a potentially life threatening condition which affects 1 in 2 patients in the Intensive Care Unit (ICU). Patients often need dialysis treatment, also called renal replacement therapy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- age ≥ 18 years
- patient weight ≥ 55 kg
- plan to start CRRT or within 24 hours of having started CRRT for AKI
- expected to survive and receive CRRT for a duration of ≥ 48 hours
You likely can't join if
- indication for sustained higher dose-intensity CRRT
- end-stage kidney disease receiving maintenance dialysis
- previous receipt of RRT for AKI during the current hospitalization
- inability to comply with the requirements of the study protocol
The study team makes the final eligibility decision.
Where it's taking place
- London, Greater London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, Greater London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.